Bioanalytical Testing Services Market

Bioanalytical Testing Services Market (Product Type: Cell-based Assays, Virology Testing, Serology, Immunogenicity & Neutralizing Antibodies, Toxicology Services, Biomarker Testing, and Pharmacokinetic Testing) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Bioanalytical Testing Services Market Outlook 2031

  • The global bioanalytical testing services industry was valued at US$ 2.11 Bn in 2021

  • The global market is projected to advance at a CAGR of 15.7% from 2022 to 2031

  • The global market is anticipated to reach more than US$ 8.95 Bn by 2031

Analysts’ Viewpoint on Bioanalytical Testing Services Market Scenario

Bioanalytical testing is used for quantitative determination of properties of drugs and metabolites in biological fluids, primarily blood, plasma, serum, urine, or tissue extracts. Rise in demand for biopharma products and growth in usage of biosimilars for different indications, especially diabetes and cancer, are key factors projected to drive the global market. Most of the pharmaceutical companies, bioanalytical laboratories, and CROs are scaling up their bioanalytical services and investing in bioanalytical testing laboratories.

bioanalytical testing services market

Bioanalytical Testing Services Market Trends

Rise in demand for biopharma products and increase in need to develop novel bioanalytical assay platforms are the key factors driving investments in bioanalytical R&D and laboratories. Increase in trend of outsourcing laboratory testing services for quality check has encouraged companies to offer various types of services and solutions in the market. This is anticipated to propel the market. Growth in merger and acquisition activities across the globe is also augmenting the demand for bioanalytical assay services. For instance, in October 2021, BioAgilytix signed an agreement to acquire Australia-based 360biolabs.

COVID-19 Impact on Bioanalytical Testing Services Market

Bioanalytical diagnostic technologies play a crucial role in containing the COVID-19 pandemic. They are likely to help contain the future waves of the pandemic and infectious disease outbreaks. In the event of a major pandemic such as COVID-19, a combination of different diagnostic technologies (centralized and point-of-care, and reliance on multiple biomarkers) is required for effective diagnosis, treatment selection, prognosis, patient monitoring, and epidemiological surveillance.

Several biotech and pharmaceutical companies have been focusing on developing effective technologies for rapid diagnosis of COVID-19. They have been concentrating on developing vaccines/therapeutics that can help mitigate the spread of the disease by ensuring appropriateness of care across all healthcare settings and achieving high-quality outcomes. This is driving the demand for bioanalytical assay services across the globe. For instance, CIRION BioPharma Research, Inc., a GLP-certified contract research laboratory based in the U.S., announced in July 2020 that it was expanding its bioanalytical testing services to support COVID-19 drug and vaccine development.

Increase in Usage of Immunogenicity and Immune-based Therapy to Propel Immunology Segment

Immunogenicity testing is required throughout the development process to assess the immune response in preclinical models using clinical samples. Immunogenicity testing examines antibodies created against a treatment. It helps establish efficacy and safety with assurance in vaccine and biologics production or gene therapy. Hence, immunology bioanalytical tests are crucial in the clinical phase for practically all modern medicines, from monoclonal antibodies (mAbs) for oncology to vaccine programs and gene & cell therapies. Any therapy that provokes an immune response requires clinical immunological testing to ensure that the response does not jeopardize patient safety. In terms of application, immunology is likely to be the fastest growing segment of the global market during the forecast period. Therefore, increase in usage of immunogenicity and immune-based therapy is projected to boost the immunology segment during the forecast period.

Rise in R&D Investment Augmenting Mass Spectroscopy Segment

The mass spectrometry segment is projected to account for major share of the global bioanalytical testing services market by 2031. R&D spending by pharmaceutical companies has increased significantly in the last two decades. Biopharmaceutical research is supported by investments in specialties such as biopharma and precision medicine. The study of large molecules is currently a hot topic of discussion in the bioanalytical community. Growing importance of peptides and proteins as therapeutic agents, combined with the significant opportunities provided by new MS-based technology, has opened up a whole new world for bioanalytical scientists. Rise in usage of mass spectrometers in pharmaceutical and biopharmaceutical industries and adoption of new applications in the bioanalytical testing services industry are the key factors driving the mass spectroscopy segment.

Surge in Specialized Testing Services to Boost Biotech & Pharmaceuticals Companies Segment

Based on end-user, the biotech & pharmaceutical companies segment is projected to advance at a CAGR of 15.1% during the forecast period. Biotech and pharmaceutical companies are focusing on specialized testing services including gene expression analysis, liquid chromatography-mass spectrometry (LC/MS), raw material wet chemistry analysis, and metal analysis with inductive mass spectrometry (ICP-MS). Furthermore, pharmaceutical companies are increasing outsourcing of early-phase development, clinical, and laboratory testing services to boost revenue, avoid high capital spending, and decrease the time taken to validate processes and products.

Regional Outlook of Global Bioanalytical Testing Services Market

North America is projected to be a highly attractive region of the global market during the forecast period. The region accounted for more than 45% share of the global market in 2021 due to the presence of large number of patients with various chronic diseases and rise in adoption of peptides and other large molecule therapeutics. According to the Centers for Disease Control and Prevention, more than 877,500 people in the U.S. succumb to heart disease or stroke every year (i.e., one-third of all deaths). These diseases take an economic toll, costing the health care system US$ 216 Bn per year.

Europe was the second largest bioanalytical testing services market in terms of revenue in 2021. High share of the region can be ascribed to the increase in investment in biotechnology and pharmaceutical R&D activities. Furthermore, rise in in cases of chronic diseases is driving the market in Europe. For instance, cardiovascular disease (CVD) accounted for 3.9 million deaths in Europe in 2017. Around 15% of CVD deaths in the region are due to high blood sugar. Prevalence of diabetes in the region is high. It has increased rapidly in the past 10 years, rising by more than 50% in several countries in the region. Hence, increase in incidence of diseases is propelling the market in Europe.

The market in Asia Pacific is anticipated to grow at the fastest CAGR during the forecast period. Increase in clinical trial activities in emerging markets is primarily ascribed to factors such as cost savings, large treatment-naive population, retention of clinical trial participants, and constantly improving regulatory procedures. Furthermore, China's bioanalytical testing services have increased due to the growth in drug innovation and development activities in the last decade. This is expected to drive the market in the country during the forecast period.

Analysis of Key Players in Global Bioanalytical Testing Services Market

This report includes vital information about the key players operating in the global bioanalytical testing services market. Companies are focusing on strategies such as new product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. Charles River Laboratories International, Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, Syneos Health, and Frontage Labs are the prominent players operating in the global market.

Key Developments in Global Bioanalytical Testing Services Market

  • In October 2021, SGS completed clinical bioanalysis laboratory expansion in France. The addition includes a new 800 m2 building that houses additional drug development equipment as well as office space. The expansion includes chromatography and immunoassay laboratories and bioanalytical testing services, which are expected to increase production capacity. The site's existing capabilities would be supplemented with new capabilities such as mass spectrometry, immunoanalysis, clinical bioanalysis, and cell-based bioassays.
  • In September 2021, Envigo announced a partnership with Biocytogen to distribute the B-NDG triple immunodeficient and humanizable mouse mode
  • In September 2020, Almac Sciences, a member of the Almac Group, announced the addition of biologics testing to its existing suite of analytical solutions. This new offering comes on the heels of the company's announcement in 2019 of the expansion of its Ireland laboratory, from which Almac Sciences provides a comprehensive range of flexible pharmaceutical testing services to support clients' drug development programs, while adhering to industry regulations such as the FDA, EMA, and PMDA under GMP standards.

Each of these players has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments. 

Global Bioanalytical Testing Services Market Snapshot 

Attribute

Detail

Market Size Value in 2021

US$ 2.11 Bn

Market Forecast Value in 2031 

More than US$ 8.95 Bn

Compound Annual Growth Rate (CAGR)

15.7%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. 

Competition Landscape

  • Market share analysis/ranking by company (2021)

  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Testing Type
    • Cell-based Assays
    • Virology Testing
    • Serology, Immunogenicity, and Neutralizing Antibodies
    • Toxicology Services
    • Biomarker Testing
    • Pharmacokinetic Testing
    • Other services
  • Application
    • Oncology
    • Neurology
    • Metabolic Disorders
    • Hematology
    • Immunology
    • Orthopedics
    • Others
  • End-user
    • Biotech & Pharmaceuticals Company
    • CDMO & CMO
    • Clinical Research Organizations
    • Healthcare Institutes
  • Technology
    • Mass Spectrometry
    • Chromatography

Regions Covered

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Countries Covered

  • U.S.

  • Canada

  • Germany

  • U.K.

  • France

  • Italy

  • Spain

  • China

  • India

  • Japan

  • Australia & New Zealand

  • Brazil

  • Mexico

  • GCC Countries

  • South Africa

Companies Profiled

  • Charles River Laboratories International, Inc.,

  • Bioreliance Corporation

  • Intertek Group plc

  • Eurofins Scientific SE

  • BioclinResearch Laboratories

  • Labcorp

  • Wuxi AppTec

  • Envigo

  • BioAgilytix Labs

  • SyneosHealth

  • Frontage Labs

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

How big was the global bioanalytical testing services market in 2021?

The global market was valued at US$ 2.11 Bn in 2021.

How big will be the global bioanalytical testing services industry by 2031?

The global market is projected to reach more than US$ 8.95 Bn by 2031.

What was the CAGR of the global bioanalytical testing services business from 2017 to 2021?

The global market grew at a CAGR of 6% from 2017 to 2021.

What will be the CAGR of the global market during the forecast period (2022–2031)?

The global market is anticipated to grow at a CAGR of 15.7% from 2022 to 2031.

Which are the prominent trends that affect market growth?

Rise in investment in R&D facilities, surge in demand for biopharma products, and increase in need to develop novel bioanalytical testing platforms are the key factors driving the global market.

What was the market share of the leading bioanalytical testing services segment?

The cell-based bioassay segment accounted for more than 30% share of the global market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global market during the forecast period.

Who are the prominent bioanalytical testing services players?

Charles River Laboratories International Inc., Bioreliance Corporation, Intertek Group plc, Eurofins Scientific SE, BioclinResearch Laboratories, Labcorp, Wuxi AppTec, Envigo, BioAgilytix Labs, SyneosHealth, and Frontage Labs are the prominent players operating in the global market.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Bioanalytical Testing Services Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Bioanalytical Testing Services Market Analysis and Forecast, 2017–2031

            4.4.1. Market Revenue Projections (US$ Mn)

    5. Key Insights

        5.1. Technological Advancements

        5.2. Pipeline Analysis

        5.3. Key Mergers & Acquisitions

        5.4. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)

    6. Global Bioanalytical Testing Services Market Analysis and Forecast, by Testing Type

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Market Value Forecast, by Testing Type, 2017–2031

            6.3.1. Cell-based Assays

            6.3.2. Virology Testing

            6.3.3. Serology, Immunogenicity, and Neutralizing Antibodies

            6.3.4. Toxicology Services

            6.3.5. Biomarker Testing

            6.3.6. Pharmacokinetic Testing

            6.3.7. Other services

        6.4. Market Attractiveness Analysis, by Testing Type

    7. Global Bioanalytical Testing Services Market Analysis and Forecast, by Application

        7.1. Introduction & Definition

        7.2. Key Findings / Developments

        7.3. Market Value Forecast, by Application, 2017–2031

            7.3.1. Oncology

            7.3.2. Metabolic Disorders

            7.3.3. Neurology

            7.3.4. Hematology

            7.3.5. Orthopedics

            7.3.6. Immunology

            7.3.7. Other

        7.4. Market Attractiveness Analysis, by Application

    8. Global Bioanalytical Testing Services Market Analysis and Forecast, by Technology

        8.1. Introduction & Definition

        8.2. Key Findings / Developments

        8.3. Market Value Forecast, by Technology, 2017–2031

            8.3.1. Mass Spectrometry

            8.3.2. Chromatography

            8.3.3. Others

        8.4. Market Attractiveness Analysis, by Technology

    9. Global Bioanalytical Testing Services Market Analysis and Forecast, by End-user

        9.1. Introduction & Definition

        9.2. Key Findings / Developments

        9.3. Market Value Forecast, by End-user, 2017–2031

            9.3.1. Healthcare Institutes

            9.3.2. Biotech & Pharmaceuticals Company

            9.3.3. CDMO & CMO

            9.3.4. Clinical Research Organizations

        9.4. Market Attractiveness Analysis, by End-user

    10. Global Bioanalytical Testing Services Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Market Value Forecast, by Region

            10.2.1. North America

            10.2.2. Europe

            10.2.3. Asia Pacific

            10.2.4. Latin America

            10.2.5. Middle East & Africa

        10.3. Market Attractiveness Analysis, by Region

    11. North America Bioanalytical Testing Services Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Testing Type, 2017–2031

            11.2.1. Cell-based Assays

            11.2.2. Virology Testing

            11.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

            11.2.4. Toxicology Services

            11.2.5. Biomarker Testing

            11.2.6. Pharmacokinetic Testing

            11.2.7. Other services

        11.3. Market Value Forecast, by Application, 2017–2031

            11.3.1. Oncology

            11.3.2. Metabolic Disorders

            11.3.3. Neurology

            11.3.4. Hematology

            11.3.5. Orthopedics

            11.3.6. Immunology

            11.3.7. Other

        11.4. Market Value Forecast, by Technology, 2017–2031

            11.4.1. Mass Spectrometry

            11.4.2. Chromatography

            11.4.3. Others

        11.5. Market Value Forecast, by End-user, 2017–2031

            11.5.1. Healthcare Institutes

            11.5.2. Biotech & Pharmaceuticals Company

            11.5.3. CDMO & CMO

            11.5.4. Clinical Research Organizations

        11.6. Market Value Forecast, by Country, 2017–2031

            11.6.1. U.S.

            11.6.2. Canada

        11.7. Market Attractiveness Analysis

            11.7.1. By Testing Type

            11.7.2. By Application

            11.7.3. By Technology

            11.7.4. By End-user

            11.7.5. By Country

    12. Europe Bioanalytical Testing Services Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Testing Type, 2017–2031

            12.2.1. Cell-based Assays

            12.2.2. Virology Testing

            12.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

            12.2.4. Toxicology Services

            12.2.5. Biomarker Testing

            12.2.6. Pharmacokinetic Testing

            12.2.7. Other Services

        12.3. Market Value Forecast, by Application, 2017–2031

            12.3.1. Oncology

            12.3.2. Metabolic Disorders

            12.3.3. Neurology

            12.3.4. Hematology

            12.3.5. Orthopedics

            12.3.6. Immunology

            12.3.7. Other

        12.4. Market Value Forecast, by Technology, 2017–2031

            12.4.1. Mass Spectrometry

            12.4.2. Chromatography

            12.4.3. Others

        12.5. Market Value Forecast, by End-user, 2017–2031

            12.5.1. Healthcare Institutes

            12.5.2. Biotech & Pharmaceuticals Company

            12.5.3. CDMO & CMO

            12.5.4. Clinical Research Organizations

        12.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            12.6.1. Germany

            12.6.2. U.K.

            12.6.3. France

            12.6.4. Spain

            12.6.5. Italy

            12.6.6. Rest of Europe

        12.7. Market Attractiveness Analysis

            12.7.1. By Testing Type

            12.7.2. By Application

            12.7.3. By Technology

            12.7.4. By End-user

            12.7.5. By Country/Sub-region

    13. Asia Pacific Bioanalytical Testing Services Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Testing Type, 2017–2031

            13.2.1. Cell-based Assays

            13.2.2. Virology Testing

            13.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

            13.2.4. Toxicology Services

            13.2.5. Biomarker Testing

            13.2.6. Pharmacokinetic Testing

            13.2.7. Other Services

        13.3. Market Value Forecast, by Application, 2017–2031

            13.3.1. Oncology

            13.3.2. Metabolic Disorders

            13.3.3. Neurology

            13.3.4. Hematology

            13.3.5. Orthopedics

            13.3.6. Immunology

            13.3.7. Other

        13.4. Market Value Forecast, by Technology, 2017–2031

            13.4.1. Mass Spectrometry

            13.4.2. Chromatography

            13.4.3. Others

        13.5. Market Value Forecast, by End-user, 2017–2031

            13.5.1. Healthcare Institutes

            13.5.2. Biotech & Pharmaceuticals Company

            13.5.3. CDMO & CMO

            13.5.4. Clinical Research Organizations

        13.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            13.6.1. China

            13.6.2. Japan

            13.6.3. India

            13.6.4. Australia & New Zealand

            13.6.5. Rest of Asia Pacific

        13.7. Market Attractiveness Analysis

            13.7.1. By Testing Type

            13.7.2. By Application

            13.7.3. By Technology

            13.7.4. By End-user

            13.7.5. By Country/Sub-region

    14. Latin America Bioanalytical Testing Services Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value Forecast, by Testing Type, 2017–2031

            14.2.1. Cell-based Assays

            14.2.2. Virology Testing

            14.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

            14.2.4. Toxicology Services

            14.2.5. Biomarker Testing

            14.2.6. Pharmacokinetic Testing

            14.2.7. Other Services

        14.3. Market Value Forecast, by Application, 2017–2031

            14.3.1. Oncology

            14.3.2. Metabolic Disorders

            14.3.3. Neurology

            14.3.4. Hematology

            14.3.5. Orthopedics

            14.3.6. Immunology

            14.3.7. Other

        14.4. Market Value Forecast, by Technology, 2017–2031

            14.4.1. Mass Spectrometry

            14.4.2. Chromatography

            14.4.3. Others

        14.5. Market Value Forecast, by End-user, 2017–2031

            14.5.1. Healthcare Institutes

            14.5.2. Biotech & Pharmaceuticals Company

            14.5.3. CDMO & CMO

            14.5.4. Clinical Research Organizations

        14.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            14.6.1. Brazil

            14.6.2. Mexico

            14.6.3. Rest of Latin America

        14.7. Market Attractiveness Analysis

            14.7.1. By Testing Type

            14.7.2. By Application

            14.7.3. By Technology

            14.7.4. By End-user

            14.7.5. By Country/Sub-region

    15. Middle East & Africa Bioanalytical Testing Services Market Analysis and Forecast

        15.1. Introduction

            15.1.1. Key Findings

        15.2. Market Value Forecast, by Testing Type, 2017–2031

            15.2.1. Cell-based Assays

            15.2.2. Virology Testing

            15.2.3. Serology, Immunogenicity, and Neutralizing Antibodies

            15.2.4. Toxicology Services

            15.2.5. Biomarker Testing

            15.2.6. Pharmacokinetic Testing

            15.2.7. Other Services

        15.3. Market Value Forecast, by Application, 2017–2031

            15.3.1. Oncology

            15.3.2. Metabolic Disorders

            15.3.3. Neurology

            15.3.4. Hematology

            15.3.5. Orthopedics

            15.3.6. Immunology

            15.3.7. Other

        15.4. Market Value Forecast, by Technology, 2017–2031

            15.4.1. Mass Spectrometry

            15.4.2. Chromatography

            15.4.3. Others

        15.5. Market Value Forecast, by End-user, 2017–2031

            15.5.1. Healthcare Institutes

            15.5.2. Biotech & Pharmaceuticals Company

            15.5.3. CDMO & CMO

            15.5.4. Clinical Research Organizations

        15.6. Market Value Forecast, by Country/Sub-region, 2017–2031

            15.6.1. GCC Countries

            15.6.2. South Africa

            15.6.3. Rest of Middle East & Africa

        15.7. Market Attractiveness Analysis

            15.7.1. By Testing Type

            15.7.2. By Application

            15.7.3. By Technology

            15.7.4. By End-user

            15.7.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by tier and size of companies)

        16.2. Company Profiles

        16.3. Company Profiles

            16.3.1. Charles River Laboratories International, Inc.

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Product Portfolio

                16.3.1.3. SWOT Analysis

                16.3.1.4. Strategic Overview

            16.3.2. Bioreliance Corporation

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Product Portfolio

                16.3.2.3. Financial Overview

                16.3.2.4. SWOT Analysis

                16.3.2.5. Strategic Overview

            16.3.3. Intertek Group plc

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Product Portfolio

                16.3.3.3. SWOT Analysis

                16.3.3.4. Strategic Overview

            16.3.4. Eurofins Scientific SE

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Product Portfolio

                16.3.4.3. Financial Overview

                16.3.4.4. SWOT Analysis

                16.3.4.5. Strategic Overview

            16.3.5. BioclinResearch Laboratories

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Product Portfolio

                16.3.5.3. Financial Overview

                16.3.5.4. SWOT Analysis

                16.3.5.5. Strategic Overview

            16.3.6. Labcorp

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Product Portfolio

                16.3.6.3. SWOT Analysis

                16.3.6.4. Strategic Overview

            16.3.7. Wuxi AppTec

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Product Portfolio

                16.3.7.3. Financial Overview

                16.3.7.4. SWOT Analysis

                16.3.7.5. Strategic Overview

            16.3.8. Envigo

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Product Portfolio

                16.3.8.3. Financial Overview

                16.3.8.4. SWOT Analysis

                16.3.8.5. Strategic Overview

            16.3.9. BioAgilytix Labs

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Product Portfolio

                16.3.9.3. SWOT Analysis

                16.3.9.4. Strategic Overview

            16.3.10. SyneosHealth

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Product Portfolio

                16.3.10.3. SWOT Analysis

                16.3.10.4. Strategic Overview

            16.3.11. Frontage Labs

                16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.11.2. Product Portfolio

                16.3.11.3. SWOT Analysis

                16.3.11.4. Strategic Overview

    List of Tables

    Table 01: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 02: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 03: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 04: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Application, 2017‒2031

    Table 05: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by technology, 2017‒2031

    Table 06: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by technology, 2017‒2031

    Table 07: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Region, 2017–2031

    Table 08: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 09: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 10: North America Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

    Table 11: North America Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

    Table 12: North America Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 13: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 14: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 15: Europe Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

    Table 16: Europe Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

    Table 17: Europe Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 18: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 19: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 20: Asia Pacific Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

    Table 21: Asia Pacific Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

    Table 22: Asia Pacific Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 23: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 24: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 25: Latin America Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

    Table 26: Latin America Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

    Table 27: Latin America Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

    Table 28: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

    Table 29: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, by Testing Type, 2017–2031

    Table 30: Middle-East & Africa Pericardial Patches Market (US$ Mn) Forecast, by Technology, 2017–2031

    Table 31: Middle-East & Africa Bioanalytical Testing Services Market (US$ Mn) Forecast, by Application, 2017–2031

    Table 32: Middle-East & Africa Bioanalytical Testing Services Market (US$ Mn) Forecast, by End-user, 2017–2031

    List of Figures

    Figure 01: Global Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 02: Global Bioanalytical Testing Services Market Value Share, by Testing Type, 2021

    Figure 03: Global Bioanalytical Testing Services Market Value Share, by Technology, 2021

    Figure 04: Global Bioanalytical Testing Services Market Value Share, by Application, 2021

    Figure 05: Global Bioanalytical Testing Services Market Value Share, by End-user, 2021

    Figure 06: Global Bioanalytical Testing Services Market Value Share, by Region, 2021

    Figure 07: Global Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

    Figure 08: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

    Figure 09: Global Bioanalytical Testing Services Market (US$ Mn), by Cell-based Assays, 2017–2031

    Figure 10: Global Bioanalytical Testing Services Market (US$ Mn), by Virology Testing, 2017–2031

    Figure 11: Global Bioanalytical Testing Services Market (US$ Mn), by Serology, Immunogenicity, and Neutralizing Antibodies, 2017–2031

    Figure 12: Global Bioanalytical Testing Services Market (US$ Mn), by Toxicology Services, 2017–2031

    Figure 13: Bioanalytical Testing Services Market (US$ Mn), by Biomarker Testing, 2017–2031

    Figure 14: Global Bioanalytical Testing Services Market (US$ Mn), by Pharmacokinetic Testing, 2017–2031

    Figure 15: Global Bioanalytical Testing Services Market (US$ Mn), by Other services, 2017–2031

    Figure 16: Global Bioanalytical Testing Services Market, by Application, 2021 and 2031

    Figure 17: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2022–2031

    Figure 18: Global Bioanalytical Testing Services Market (US$ Mn), by Oncology, 2017–2031

    Figure 19: Global Bioanalytical Testing Services Market (US$ Mn), by Metabolic Disorders, 2017–2031

    Figure 20: Global Bioanalytical Testing Services Market (US$ Mn), by Neurology, 2017–2031

    Figure 21: Global Bioanalytical Testing Services Market (US$ Mn), by Hematology, 2017–2031

    Figure 22: Global Bioanalytical Testing Services Market (US$ Mn), by Orthopedics, 2017–2031

    Figure 23: Global Bioanalytical Testing Services Market (US$ Mn), by Immunology, 2017–2031

    Figure 24: Global Bioanalytical Testing Services Market (US$ Mn), by Other, 2017–2031

    Figure 25: Global Bioanalytical Testing Services Market, by Technology 2021 and 2031

    Figure 26: Global Bioanalytical Testing Services Market Attractiveness Analysis, Technology, 2022–2031

    Figure 27: Global Bioanalytical Testing Services Market (US$ Mn), by Mass Spectrometry, 2017–2031

    Figure 28: Global Bioanalytical Testing Services Market (US$ Mn), by Chromatography, 2017–2031

    Figure 29: Global Bioanalytical Testing Services Market (US$ Mn), by Others, 2017–2031

    Figure 30: Global Bioanalytical Testing Services Market, by End-user 2021 and 2031

    Figure 31: Global Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

    Figure 32: Global Bioanalytical Testing Services Market (US$ Mn), by Healthcare Institutes, 2017–2031

    Figure 33: Global Bioanalytical Testing Services Market (US$ Mn), by Biotech & Pharmaceuticals Company, 2017–2031

    Figure 34: Global Bioanalytical Testing Services Market (US$ Mn), by CDMO & CMO, 2017–2031

    Figure 35: Global Bioanalytical Testing Services Market (US$ Mn), by Clinical Research Organizations, 2017–2031

    Figure 36: Global Bioanalytical Testing Services Market Value Share Analysis, by Region, 2021 and 2031

    Figure 37: Global Bioanalytical Testing Services Market Attractiveness Analysis, by Region, 2022–2031

    Figure 38: North America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 39: North America Bioanalytical Testing Services Market Value Share Analysis, by Country, 2021 and 2031

    Figure 40: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Country, 2022–2031 

    Figure 41: North America Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

    Figure 42: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

    Figure 43: North America Bioanalytical Testing Services Market, Technology, 2021 and 2031

    Figure 44: North America Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 45: North America Bioanalytical Testing Services Market, by Application, 2021 and 2031

    Figure 46: North America Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031

    Figure 47: North America Bioanalytical Testing Services Market, by End-user, 2021 and 2031

    Figure 48: North America Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

    Figure 49: Europe Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 50: Europe Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 51: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 52: Europe Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

    Figure 53: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

    Figure 54: Europe Bioanalytical Testing Services Market, Technology, 2021 and 2031

    Figure 55: Europe Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 56: Europe Bioanalytical Testing Services Market, by Application, 2021 and 2031

    Figure 57: Europe Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031

    Figure 58: Europe Bioanalytical Testing Services Market, by End-user, 2021 and 2031

    Figure 59: Europe Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

    Figure 60: Asia Pacific Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 61: Asia Pacific Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 62: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 63: Asia Pacific Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

    Figure 64: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

    Figure 65: Asia Pacific Bioanalytical Testing Services Market, Technology, 2021 and 2031

    Figure 66: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 67: Asia Pacific Bioanalytical Testing Services Market, by Application, 2021 and 2031

    Figure 68: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, Application, 2022–2031

    Figure 69: Asia Pacific Bioanalytical Testing Services Market, by End-user, 2021 and 2031

    Figure 70: Asia Pacific Bioanalytical Testing Services Market Attractiveness Analysis, End-user, 2022–2031

    Figure 71: Latin America Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 72: Latin America Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 73: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 74: Latin America Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

    Figure 75: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

    Figure 76: Latin America Bioanalytical Testing Services Market, Technology, 2021 and 2031

    Figure 77: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 78: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2021 and 2031

    Figure 79: Latin America Bioanalytical Testing Services Market, Application, 2022–2031

    Figure 80: Latin America Bioanalytical Testing Services Market Attractiveness Analysis, by End-user, 2021 and 2031

    Figure 81: Latin America Bioanalytical Testing Services Market, End-user, 2022–2031

    Figure 82: Middle-East & Africa Bioanalytical Testing Services Market Value (US$ Mn) Forecast, 2017–2031

    Figure 83: Middle-East & Africa Bioanalytical Testing Services Market Value Share Analysis, by Country/Sub-region, 2021 and 2031

    Figure 84: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Country/Sub-region, 2022–2031 

    Figure 85: Middle-East & Africa Bioanalytical Testing Services Market, by Testing Type, 2021 and 2031

    Figure 86: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Testing Type, 2022–2031

    Figure 87: Middle-East & Africa Bioanalytical Testing Services Market, Technology, 2021 and 2031

    Figure 88: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Technology, 2022–2031

    Figure 89: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by Application, 2021 and 2031

    Figure 90: Middle-East & Africa Bioanalytical Testing Services Market, Application, 2022–2031

    Figure 91: Middle-East & Africa Bioanalytical Testing Services Market Attractiveness Analysis, by End-user, 2021 and 2031

    Figure 92: Middle-East & Africa Bioanalytical Testing Services Market, End-user, 2022–2031

Copyright © Transparency Market Research, Inc. All Rights reserved